The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Welch, J.
* Articles by Redmond, D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Welch, J.
* Articles by Redmond, D.

J Neuropsychiatry Clin Neurosci 1994; 6:250-256
Copyright © 1994 by American Neuropsychiatric Association


REGULAR ARTICLES

Clozapine-induced seizures and EEG changes

J Welch, T Manschreck and D Redmond
New Hampshire Hospital, Division of Neurology, Dartmouth Medical School, Concord 03301.

Clozapine, an atypical antipsychotic drug, is widely used in refractory schizophrenia. At New Hampshire Hospital, 7 of the first 35 patients treated (20%) had convulsions. Patterns were tonic-clonic (5), complex partial (2), and myoclonic (3). Seizures were dose-related and may be anticholinergic in etiology. EEG changes are frequent with clozapine, particularly as dosage is increased. Twenty-six of 35 patients (74%) had EEG abnormalities at some time during clozapine treatment. EEG is a sensitive means of detecting clinical toxicity. When EEG abnormalities (slowing, dysrhythmia, or paroxysmal discharges) are detected, immediately lowering the dose by at least 25-50 mg per day and adjusting weekly until EEG returns to baseline can reduce the incidence of seizures.


This article has been cited by other articles:


Home page
Psychiatr. Bull.Home page
A. Sparshatt, E. Whiskey, and D. Taylor
Valproate as prophylaxis for clozapine-induced seizures: survey of practice
Psychiatr. Bull., July 1, 2008; 32(7): 262 - 265.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. Wichniak, T. Szafranski, A. Wierzbicka, E. Waliniowska, and W. Jernajczyk
Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment
J Psychopharmacol, January 1, 2006; 20(1): 80 - 85.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
F. Centorrino, B. H. Price, M. Tuttle, W.-M. Bahk, J. Hennen, M. J. Albert, and R. J. Baldessarini
EEG Abnormalities During Treatment With Typical and Atypical Antipsychotics
Am J Psychiatry, January 1, 2002; 159(1): 109 - 115.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
B. Panagiotis
Grand Mal Seizures With Liver Toxicity in a Case of Clozapine Treatment
J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 117a - 118.
[Full Text]


Home page
Arch Gen PsychiatryHome page
S. Kumra, J. A. Frazier, L. K. Jacobsen, K. McKenna, C. T. Gordon, M. C. Lenane, S. D. Hamburger, A. K. Smith, K. E. Albus, J. Alaghband-Rad, et al.
Childhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
Arch Gen Psychiatry, December 1, 1996; 53(12): 1090 - 1097.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1994 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org